SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Naturade (NRDC)--a turnaround

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: leigh aulper who wrote ()7/16/1998 12:44:00 PM
From: leigh aulper   of 17
 
Naturade to Announce New Consumer Focus Strategy For Natural Products Channel

PARAMOUNT, Calif., July 16 /PRNewswire/ -- Naturade, Inc.'s (OTC Bulletin Board: NRDC) recently appointed Chairman, Ronald Ahrens, and Chief Executive Officer, Bill Stewart, will announce an invigorated, consumer focus growth strategy for the natural products channel. Naturade(TM) will present a strategy driven by introductions of superior new products supported by new attractive packaging graphics, and aggressive in-store merchandising programs. The goal is to increase Naturade's business for its retail and distributor partners.

"My first job is to grow our core business for our natural products channel retail and distributor partners," said CEO Bill Stewart. "We're doing this by substantially upgrading our consumer focus to deliver a superior product that offers meaningful value to consumers in order to drive increased business performance for our partners. We have recently introduced, and will continue to introduce, new differentiated products, supported by new packaging graphics and aggressive, in-store merchandising programs for the natural products channel. The initial products and programs of our new strategy will be introduced to the natural products industry at the National Nutritional Foods Association Trade Show in San Antonio, Texas on July 15."

Mr. Ahrens is the immediate past CEO of Merck Consumer Healthcare, Inc., and was responsible for supervising the Johnson & Johnson Merck joint venture which successfully introduced Pepcid AC(TM), the leading OTC switch product acid blocker. Prior to joining Merck, Mr. Ahrens served as the president of Bristol Myers Products Division and Richardson Vicks Health Care Division where he was responsible for such brands as Nyquil(TM) and Oil of Olay(TM). Mr. Stewart is a 16 year Richardson Vicks veteran where he was Director of Sales, before becoming President of the Thompson's Minwax Company, where he directed the increase of sales of the company from under $40 million to over $180 million annually.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext